Literature DB >> 2654590

Life satisfaction across treatment methods for patients with end-stage renal failure.

P L Morris1, B Jones.   

Abstract

After a report which challenged the generally-held view that renal-transplant recipients have a psychological advantage compared with patients who undergo dialysis, we surveyed the quality of life and psychological distress in all patients who were managed by renal transplantation or dialysis at The Royal Newcastle Hospital Renal Unit. A questionnaire was mailed to patients which covered demographic daily illness severity; the quality of life (satisfaction with life in general, general health, and sexual, family and social relationships); a 28-item general-health questionnaire; a life-event schedule; and a locus-of-control scale. The response rate was 88%. Data were obtained on 138 subjects of whom half (69 subjects) were renal-transplant recipients. The other 69 patients were divided between those who underwent haemodialysis at home (24 patients); those who underwent haemodialysis in a hospital centre (24 patients); and those who underwent continuous ambulatory peritoneal dialysis (21 patients). The study showed that while transplant recipients rated highest in the various aspects of quality of life, that of patients who underwent haemodialysis at home was nearly equivalent. Although patients with continuous ambulatory peritoneal dialysis were ranked third in terms of their quality of life, this clearly exceeded that of the group that underwent haemodialysis in a hospital centre, which generally shared very-similar demographic characteristics. Contrary to general expectations, no clear difference was found across the four treatment modalities in the proportion of patients who were disturbed psychologically or who had a history of treatment for "nervous" problems. The results confirm the superiority of renal transplantation in the treatment of end-stage renal disease but highlights the role of continuous ambulatory peritoneal dialysis as a well-tolerated alternative in the treatment of end-stage renal disease.

Entities:  

Mesh:

Year:  1989        PMID: 2654590     DOI: 10.5694/j.1326-5377.1989.tb136562.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

Review 1.  New trends on health related quality of life assessment in end-stage renal disease patients.

Authors:  Pablo Rebollo; Francisco Ortega
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Is lack of suitable housing a barrier to home-based dialysis therapy for patients with end-stage renal disease? A cohort study.

Authors:  Suzanne H Forbes; Kieran McCafferty; Trevor Lawson; Meagan Stoby-Fields; Martin Raftery; Muhammad Magdi Yaqoob
Journal:  BMJ Open       Date:  2013-02-10       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.